Riik: Iirimaa
keel: inglise
Allikas: HPRA (Health Products Regulatory Authority)
Paracetamol
Haleon Ireland Limited
N02BE01
Paracetamol
Soluble tablet
paracetamol
2022-10-21
100 1226 Pharmacode Standard Barcode Type Barcode Number: Magnification: BARCODE INFO BWR: 0 Micrometre 70% 50% 1. 20% BLACK Dungarvan Ireland PANADOL ACTIFAST OTC.LT.009 Offset - Lithography N/A 62000000206200 PK 201259356 Leaflet OTC.LT.SPEC.009 1226 N/A TR2945280/A 0000018504 AIP_CHAMPS_2022_HALEON_Version 1 27 - Jul - 2023 V1 STUDIO LOCATION: NON PRODUCTION D2A AWP NO: Artwork Information Panel CHAMPS NO: MANUFACTURING SITE: SITE COMPONENT NO: SITE CHANGE CONTROL NO: APPROVING MARKET: PRODUCT MARKET TRADE NAME: MATERIAL SPEC NO: PRINT PROCESS: TECHNICAL DRAWING NO: BARCODE NO: BAR WIDTH REDUCTION: PHARMA CODE NO: TOTAL NUMBER OF COLOURS INCLUDING VARNISH & FOILS: TOTAL SPECIAL FINISHES: X No MICRO TEXT: 7.0pt 7.0pt 7.9pt 85% BODY TEXT SIZE: N/A FORMULATION CODE SMALLEST TEXT SIZE: LEADING: HORIZONTAL SCALE: PRODUCTION COMPONENT TYPE: 0 1 EUROPE READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. This medicine is available without prescription. However, you still need to take Panadol ActiFast Lemon Soluble Tablets carefully to get the best results from it. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. • You must contact a doctor if your symptoms worsen or do not improve. • If any of the side effects get serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Panadol ActiFast Lemon Soluble Tablets are and what they are used for 2. Before you take Panadol ActiFast Lemon Soluble Tablets 3. How to take Panadol ActiFast Lemon Soluble Tablets 4. Possible side effects 5. How to store Panadol ActiFast Lemon Soluble Tablets 6. Contents of the pack and other information 1. WHAT PANADOL ACTIFAST LEMON SOLUBLE TABLETS ARE AND WHAT THEY ARE USED FOR Panadol ActiFast Lemon Soluble Tablets provide fast and effective relief of headaches, toothache, backache, rheumatic and muscle pains and period pain. It also relieves sore throat and the fev Lugege kogu dokumenti
Health Products Regulatory Authority 10 January 2024 CRN00F1W1 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Panadol Actifast Lemon 500 mg Soluble Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 500 mg of paracetamol. Excipients with known effect: each tablet contains 427 mg sodium and 50 mg sorbitol. For a full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Soluble Tablet Round white, flat tablets with bevelled edges, plain on both sides 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS As a mild analgesic and antipyretic. The tablets are recommended for use in the short-term management of the symptoms of headache, toothache, menstrual pain, musculoskeletal disorders and for symptoms of common colds and 'flu including sore throat, headache, muscle ache and fever. Panadol may also be used in the symptomatic relief of mild to moderate pain associated with osteoarthritis, as diagnosed by a doctor. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For oral administration only. ADULTS (INCLUDING THE ELDERLY) AND CHILDREN AGED 16 YEARS AND OVER: One or two tablets dissolved in water up to 4 times daily as required. CHILDREN AGED 10-15 YEARS: One tablet dissolved in water up to 4 times daily as required. Children should not be given paracetamol for more than 3 days without consulting a doctor. Not recommended for children under the age of 10 years. Minimum dosing interval: 4 hours. Not more than 4 doses should be taken in any 24 hour period. Do not exceed the stated dose. Should not be used with other paracetamol containing products. The lowest dose necessary to achieve efficacy should be used. Renal Impairment It is recommended, when giving paracetamol to patients with renal impairment, to reduce the dose and to increase the minimum interval between each administration to at least 6 hours unless directed otherwise by a physician. See Table below. Adults: _Glomerular filtration rate_ _Dose_ 10-50 ml/min 500mg every 6 hours < 10 ml/min 500mg every 8 hours Hepa Lugege kogu dokumenti